By Ludwig Burger and Michael Erman (Reuters) -Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...

For patients who achieve complete remission on Bispecific T-cell engagers, “there is a good chance they will stay in ...